CN101544572A - 一种氨溴索衍生物及其制备方法 - Google Patents
一种氨溴索衍生物及其制备方法 Download PDFInfo
- Publication number
- CN101544572A CN101544572A CN200810084145A CN200810084145A CN101544572A CN 101544572 A CN101544572 A CN 101544572A CN 200810084145 A CN200810084145 A CN 200810084145A CN 200810084145 A CN200810084145 A CN 200810084145A CN 101544572 A CN101544572 A CN 101544572A
- Authority
- CN
- China
- Prior art keywords
- amino
- protecting group
- compound
- tertbutyloxycarbonyl
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
化合物 | 溶解度(mg/ml) |
L-丙氨酸[反式-4-[(2-氨基-3,5-二溴苯甲基)氨基]环己醇]酯二甲磺酸盐 | >500 |
L-缬氨酸[反式-4-[(2-氨基-3,5-二溴苯甲基)氨基]环己醇]酯二甲磺酸盐 | >500 |
盐酸氨溴索 | 13 |
化合物 | AUC0-t(ng.h/ml,平均值) |
L-丙氨酸[反式-4-[(2-氨基-3,5-二溴苯甲基)氨基]环己醇]酯二甲磺酸盐 | 1017 |
盐酸氨溴索 | 868 |
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100841459A CN101544572B (zh) | 2008-03-26 | 2008-03-26 | 一种氨溴索衍生物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100841459A CN101544572B (zh) | 2008-03-26 | 2008-03-26 | 一种氨溴索衍生物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101544572A true CN101544572A (zh) | 2009-09-30 |
CN101544572B CN101544572B (zh) | 2013-03-20 |
Family
ID=41191975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100841459A Expired - Fee Related CN101544572B (zh) | 2008-03-26 | 2008-03-26 | 一种氨溴索衍生物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101544572B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102351720A (zh) * | 2011-10-21 | 2012-02-15 | 南京理工大学 | 一种简易高效的氨溴素合成方法 |
CN103073439A (zh) * | 2013-02-05 | 2013-05-01 | 山东罗欣药业股份有限公司 | 一种盐酸氨溴索化合物的合成方法 |
US9518050B2 (en) | 2012-12-18 | 2016-12-13 | Almirall, S.A. | Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity |
US9562039B2 (en) | 2013-02-27 | 2017-02-07 | Almirall, S.A. | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities |
US9579316B2 (en) | 2013-07-25 | 2017-02-28 | Almirall, S.A. | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities |
TWI572602B (zh) * | 2011-11-11 | 2017-03-01 | 艾美羅有限公司 | 具有β2腎上腺素增效劑及M3毒蕈碱拮抗劑之作用之新環己胺衍生物 |
US9643961B2 (en) | 2010-05-13 | 2017-05-09 | Almirall, S.A. | Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities |
US10005771B2 (en) | 2014-09-26 | 2018-06-26 | Almirall, S.A. | Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities |
US10456390B2 (en) | 2013-07-25 | 2019-10-29 | Almirall, S.A. | Combinations comprising MABA compounds and corticosteroids |
WO2021012698A1 (zh) * | 2019-07-24 | 2021-01-28 | 成都施贝康生物医药科技有限公司 | 二溴苄基衍生物、其立体异构体或其盐及制法和应用 |
CN112745251A (zh) * | 2019-10-31 | 2021-05-04 | 华创合成制药股份有限公司 | 一种治疗祛痰化合物及其制备方法和用途 |
WO2022193368A1 (zh) * | 2021-03-17 | 2022-09-22 | 成都施贝康生物医药科技有限公司 | 反式金刚烷氨衍生物或其盐、及制备方法、组合物和用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536713A (en) * | 1966-05-10 | 1970-10-27 | Boehringer Sohn Ingelheim | N-(hydroxy-cyclohexyl)-aminobenzylamines and the salts thereof |
EP0505180A1 (en) * | 1991-03-22 | 1992-09-23 | Merck & Co. Inc. | High-content ibuprofen lysinate pharmaceutical formulation |
CN1130354A (zh) * | 1993-09-07 | 1996-09-04 | 普罗克特和廿保尔公司 | 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物 |
CN1454888A (zh) * | 2002-04-29 | 2003-11-12 | 常州市第四制药厂 | 快速溶解型氨溴索盐及制备方法 |
CN1699337A (zh) * | 2004-05-20 | 2005-11-23 | 江苏豪森药业股份有限公司 | 氨溴索半胱氨酸类似物盐及其制备方法和用途 |
-
2008
- 2008-03-26 CN CN2008100841459A patent/CN101544572B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536713A (en) * | 1966-05-10 | 1970-10-27 | Boehringer Sohn Ingelheim | N-(hydroxy-cyclohexyl)-aminobenzylamines and the salts thereof |
EP0505180A1 (en) * | 1991-03-22 | 1992-09-23 | Merck & Co. Inc. | High-content ibuprofen lysinate pharmaceutical formulation |
CN1130354A (zh) * | 1993-09-07 | 1996-09-04 | 普罗克特和廿保尔公司 | 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物 |
CN1454888A (zh) * | 2002-04-29 | 2003-11-12 | 常州市第四制药厂 | 快速溶解型氨溴索盐及制备方法 |
CN1699337A (zh) * | 2004-05-20 | 2005-11-23 | 江苏豪森药业股份有限公司 | 氨溴索半胱氨酸类似物盐及其制备方法和用途 |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9643961B2 (en) | 2010-05-13 | 2017-05-09 | Almirall, S.A. | Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities |
CN102351720A (zh) * | 2011-10-21 | 2012-02-15 | 南京理工大学 | 一种简易高效的氨溴素合成方法 |
US10300072B2 (en) | 2011-11-11 | 2019-05-28 | Almirall, S.A. | Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities |
TWI572602B (zh) * | 2011-11-11 | 2017-03-01 | 艾美羅有限公司 | 具有β2腎上腺素增效劑及M3毒蕈碱拮抗劑之作用之新環己胺衍生物 |
US9757383B2 (en) | 2011-11-11 | 2017-09-12 | Almirall, S.A. | Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities |
US9518050B2 (en) | 2012-12-18 | 2016-12-13 | Almirall, S.A. | Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity |
CN103073439A (zh) * | 2013-02-05 | 2013-05-01 | 山东罗欣药业股份有限公司 | 一种盐酸氨溴索化合物的合成方法 |
CN103073439B (zh) * | 2013-02-05 | 2013-10-16 | 山东罗欣药业股份有限公司 | 一种盐酸氨溴索化合物的合成方法 |
US9562039B2 (en) | 2013-02-27 | 2017-02-07 | Almirall, S.A. | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities |
US9579316B2 (en) | 2013-07-25 | 2017-02-28 | Almirall, S.A. | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities |
US10456390B2 (en) | 2013-07-25 | 2019-10-29 | Almirall, S.A. | Combinations comprising MABA compounds and corticosteroids |
US10005771B2 (en) | 2014-09-26 | 2018-06-26 | Almirall, S.A. | Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities |
WO2021012698A1 (zh) * | 2019-07-24 | 2021-01-28 | 成都施贝康生物医药科技有限公司 | 二溴苄基衍生物、其立体异构体或其盐及制法和应用 |
JP2022542675A (ja) * | 2019-07-24 | 2022-10-06 | チォンドウ シーベイカン バイオメディカル テクノロジー カンパニー リミテッド | ジブロモベンジル基誘導体、その立体異性体又はその塩、並びに製造方法及び応用 |
JP7344607B2 (ja) | 2019-07-24 | 2023-09-14 | チォンドウ シーベイカン バイオメディカル テクノロジー カンパニー リミテッド | ジブロモベンジル基誘導体、その立体異性体又はその塩、ジブロモベンジル基誘導体の製造方法、呼吸器疾患を予防及び治療する薬物、去痰薬及び薬物組成物 |
CN112745251A (zh) * | 2019-10-31 | 2021-05-04 | 华创合成制药股份有限公司 | 一种治疗祛痰化合物及其制备方法和用途 |
WO2021082501A1 (zh) * | 2019-10-31 | 2021-05-06 | 华创合成制药股份有限公司 | 一种祛痰化合物及其制备方法和用途 |
JP2023500101A (ja) * | 2019-10-31 | 2023-01-04 | 華創合成制薬股▲ふん▼有限公司 | 去痰化合物、その製造方法及び使用 |
CN112745251B (zh) * | 2019-10-31 | 2023-10-27 | 华创合成制药股份有限公司 | 一种治疗祛痰化合物及其制备方法和用途 |
AU2020375675B2 (en) * | 2019-10-31 | 2023-11-09 | HC Synthetic Pharmaceutical Co., Ltd. | Expectorant compound and preparation method and use thereof |
JP7393052B2 (ja) | 2019-10-31 | 2023-12-06 | 華創合成制薬股▲ふん▼有限公司 | 去痰化合物、その製造方法及び使用 |
WO2022193368A1 (zh) * | 2021-03-17 | 2022-09-22 | 成都施贝康生物医药科技有限公司 | 反式金刚烷氨衍生物或其盐、及制备方法、组合物和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101544572B (zh) | 2013-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101544572B (zh) | 一种氨溴索衍生物及其制备方法 | |
KR101473028B1 (ko) | 인플루엔자 치료제 | |
WO2013060258A1 (zh) | 伸筋草碱a-c、其制法和其药物组合物与用途 | |
CA2606207C (en) | Pharmaceutical composition | |
JP6697808B2 (ja) | 感覚有毛細胞の死を防ぐまたは処置するための化合物と方法 | |
WO2009140887A1 (zh) | 一种灯盏花乙素衍生物及其制备方法、药物组合物和用途 | |
AU2020309505A1 (en) | Design and efficient synthesis of lipid-fluorescein conjugates for CAR-T cell therapy | |
CN101712676B (zh) | 水溶性葛根素衍生物及其制备方法与用途 | |
CN101289438A (zh) | 3-(3′-羟基)-丁基苯酞酯及其制法和用途 | |
CN109956975A (zh) | 肝递送恩替卡韦前体药物核苷环磷酸酯化合物及应用 | |
CN101195615A (zh) | 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物 | |
CN101429185B (zh) | 槲皮素两种晶型物质、其制法和其药物组合物与用途 | |
EP2767533A1 (en) | Derivative of butylphthalide and preparation method and use thereof | |
KR20210125994A (ko) | 비정질 스파르센탄 조성물 | |
CN103012345B (zh) | 木犀草素α晶型物质、其制法和其药物组合物与用途 | |
SG188472A1 (en) | Prodrugs of guanfacine | |
CN101993417A (zh) | 磷酸二甲啡烷的稳定新晶型 | |
CN102250066B (zh) | 法舒地尔衍生物及其制备方法 | |
CN101857622B (zh) | 一种腺苷衍生物及其制备方法和应用 | |
CN109422751A (zh) | 一类具有降解酪氨酸蛋白激酶jak3活性的化合物 | |
RU2699669C1 (ru) | Новые составы N-карбамоилметил-4-фенил-2-пирролидона | |
CN111960978A (zh) | 一种具有神经保护活性的s-烯丙基-l-半胱氨酸取代酪醇衍生物合成方法及其应用 | |
CN102241644B (zh) | α-氨基-3-芳基丙酰胺基噻唑衍生物、其制备方法和用途 | |
CN109721557A (zh) | 来曲唑晶ii型固体物质及制备方法和其药物组合物与用途 | |
CN102126973A (zh) | 一种二元酯酸的葡甲胺盐化合物,其制备方法和药物应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU HANSOH MEDICAL GROUP CO.,LTD. Free format text: FORMER OWNER: LIANYUNGANG HENGBANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20131113 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131113 Address after: 222047 Lianyungang Development Zone, Jiangsu Patentee after: Jiangsu Hansoh Medical Group Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Patentee before: Lianyungang Hengbang Pharmaceutical Technology Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160315 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Patentee after: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL CO., LTD. Address before: 222047 Lianyungang Development Zone, Jiangsu Patentee before: Jiangsu Hansoh Medical Group Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130320 Termination date: 20210326 |
|
CF01 | Termination of patent right due to non-payment of annual fee |